Patents by Inventor Lingling Peng

Lingling Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reversibly blocked nucleoside analogues and their use
    Patent number: 12195493
    Abstract: Reversibly blocked nucleoside analogues and methods of using such nucleoside analogues for sequencing of nucleic acids are provided.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: January 14, 2025
    Assignees: MGI Tech Co., Ltd., BGI Shenzhen
    Inventors: Handong Li, Snezana Drmanac, Radoje Drmanac, Xun Xu, Lingling Peng, Scott Gablenz
  • SEQUENCING CHIP AND MANUFACTURING METHOD THEREFOR
    Publication number: 20210384031
    Abstract: Provided are a chip matrix, a sequencing chip, and a manufacturing method thereof. The chip matrix includes: a wafer layer (111), the wafer layer (111) having cutting lines that are evenly distributed thereon; a first silicon oxide layer (112), the first silicon oxide layer (112) being made of silicon oxide and formed on an upper surface of the wafer layer (111); a transition metal oxide layer (113), the transition metal oxide layer (113) being made of transition metal oxide and formed on an upper surface of the first silicon oxide layer (112). The chip matrix has characteristics such as resistances against high temperature, high humidity and other harsh environments. Meanwhile, by changing pH, surfactant and other components of a solution containing sequences to be sequenced, a surface functional region of the chip matrix can specifically adsorb a sequence to be sequenced.
    Type: Application
    Filed: July 15, 2021
    Publication date: December 9, 2021
    Applicant: BGI SHENZHEN
    Inventors: Shifeng Li, Tengyue Li, Yuan Li, Zhaohui Wang, Xueqin Jiang, Jiacheng Chen, Aoli Wang, Fuxing Huang, Xiaogang Song, Lingling Peng, Handong Li, Wenwei Zhang
  • REVERSIBLY BLOCKED NUCLEOSIDE ANALOGUES AND THEIR USE
    Publication number: 20210206794
    Abstract: Reversibly blocked nucleoside analogues and methods of using such nucleoside analogues for sequencing of nucleic acids are provided.
    Type: Application
    Filed: March 22, 2021
    Publication date: July 8, 2021
    Inventors: Handong Li, Snezana Drmanac, Radoje Drmanac, Xun Xu, Lingling Peng, Scott Gablenz
  • Reversibly blocked nucleoside analogues and their use
    Patent number: 10988501
    Abstract: Reversibly blocked nucleoside analogues and methods of using such nucleoside analogues for sequencing of nucleic acids are provided.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: April 27, 2021
    Inventors: Handong Li, Snezana Drmanac, Radoje Drmanac, Xun Xu, Lingling Peng, Scott Gablenz
  • Reversibly Blocked Nucleoside Analogues And Their Use
    Publication number: 20190144482
    Abstract: Reversibly blocked nucleoside analogues and methods of using such nucleoside analogues for sequencing of nucleic acids are provided.
    Type: Application
    Filed: April 21, 2017
    Publication date: May 16, 2019
    Inventors: Handong Li, Snezana Drmanac, Radoje Drmanac, Xun Xu, Lingling Peng, Scott Gablenz
  • Imidazole derivatives useful for controlling microbial growth
    Patent number: 9723837
    Abstract: Disclosure is provided for 1,4,5-substituted amino imidazole compounds useful to control microbial growth, compositions including these compounds, devices including these compounds, and methods of using the same.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: August 8, 2017
    Assignee: North Carolina State University
    Inventors: Christian Melander, Zhaoming Su, Lingling Peng
  • Imidazole Derivatives Useful for Controlling Microbial Growth
    Publication number: 20140364474
    Abstract: Disclosure is provided for 1,4,5-substituted amino imidazole compounds useful to control microbial growth, compositions including these compounds, devices including these compounds, and methods of using the same.
    Type: Application
    Filed: August 21, 2014
    Publication date: December 11, 2014
    Inventors: Christian Melander, Zhaoming Su, Lingling Peng
  • Imidazole derivatives useful for controlling microbial growth
    Patent number: 8840912
    Abstract: Disclosure is provided for 1,4,5-substituted amino imidazole compounds useful to control microbial growth, compositions including these compounds, devices including these compounds, and methods of using the same.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: September 23, 2014
    Assignee: North Carolina State University
    Inventors: Christian Melander, Zhaoming Su, Lingling Peng